We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,930 results
  1. Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition

    Over the past decade, immune checkpoint inhibitor (ICI) therapy has been established as the standard of care for many types of cancer, but the...

    Roger J. Daly, Andrew M. Scott, ... Matthias Ernst in Molecular Cancer
    Article Open access 29 September 2022
  2. Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders

    Protein phosphatases act as key regulators of multiple important cellular processes and are attractive therapeutic targets for various diseases....

    Stephanie M. Stanford, Nunzio Bottini in Nature Reviews Drug Discovery
    Article 24 January 2023
  3. A CD22–Shp1 phosphatase axis controls integrin β7 display and B cell function in mucosal immunity

    The integrin α 4 β 7 selectively regulates lymphocyte trafficking and adhesion in the gut and gut-associated lymphoid tissue (GALT). Here, we describe...

    Romain Ballet, Martin Brennan, ... Eugene C. Butcher in Nature Immunology
    Article 15 February 2021
  4. Fas ligand intracellular signaling: does PSTPIP mediate T cell death?

    Fas and Fas ligand (FasL)-induced cell death is critical for the appropriate regulation of immune responses, especially those mediated by T cells. In...

    Rafael Cardoso Maciel Costa Silva in Apoptosis
    Article 04 October 2023
  5. PTEN in Immunity

    The tumor suppressor PTEN (Phosphatase and Tensin homolog deleted on Chromosome 10) executes critical biological functions that limit cellular growth...
    Antonella Papa, Pier Paolo Pandolfi in PI3K and AKT Isoforms in Immunity
    Chapter 2022
  6. Expression analysis of Carassius auratus-leukocyte-immune-type receptors (CaLITRs) during goldfish kidney macrophage development and in activated kidney leukocyte cultures

    Carassius auratus leukocyte immune-type receptors (CaLITRs) were recently discovered immunoregulatory receptors in goldfish that have diverse...

    Jiahui Wang, Amro M. Soliman, ... James L. Stafford in Immunogenetics
    Article 18 February 2023
  7. A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects

    Chromosome translocations in the 5q31-33 region are associated with a range of hematologic malignancies, some of which involve the platelet-derived...

    Zhe Wang, Ting Liu, ... Shuning Wei in Cancer Gene Therapy
    Article 07 August 2023
  8. Cancer Pathways

    Proliferation, differentiation, and survival of normal cells are regulated by interlinked pathways that transmit and integrate signals from growth...
    Wolfgang A. Schulz in Molecular Biology of Human Cancers
    Chapter 2023
  9. New small molecules in dermatology: for the autoimmunity, inflammation and beyond

    Objective and design

    The discovery of new inflammatory pathways and the mechanism of action of inflammatory, autoimmune, genetic, and neoplastic...

    Paulo Ricardo Criado, Daniel Lorenzini, ... Mayra Ianhez in Inflammation Research
    Article 22 May 2023
  10. Oncogenes

    Oncogenes are one important type of cancer gene and act in a dominant mode. They were first discovered in cancer-causing viruses. Retroviral...
    Wolfgang A. Schulz in Molecular Biology of Human Cancers
    Chapter 2023
  11. Targeting Pim kinases in hematological cancers: molecular and clinical review

    Decades of research has recognized a solid role for Pim kinases in lymphoproliferative disorders. Often up-regulated following JAK/STAT and tyrosine...

    Marcia Bellon, Christophe Nicot in Molecular Cancer
    Article Open access 25 January 2023
  12. TCR Signals Controlling Adaptive Immunity against Toxoplasma and Cancer

    T cells play a crucial role in adaptive immunity by recognizing and eliminating foreign pathogens and abnormal cells such as cancer cells. T cell...
    Masaaki Okamoto, Masahiro Yamamoto in Basic Immunology and Its Clinical Application
    Chapter 2024
  13. Immunohistochemistry in the Diagnosis of Primary and Secondary Cancers

    In everyday practice, pathologists often have to face the challenging task of labeling primary and secondary malignancies, sometimes on a small...
    Francesca Sanguedolce, Magda Zanelli in Handbook of Cancer and Immunology
    Living reference work entry 2022
  14. B Cell Immunity: BCRs, Antibodies and Their Effector Functions

    In this chapter, we will explain that B cells respond to antigen stimulation of their BCR with the production of antibodies. This is a key feature of...
    Carsten Carlberg, Eunike Velleuer, Ferdinand Molnár in Molecular Medicine
    Chapter 2023
  15. Role of C-Type Lectins in the Tumor Microenvironment

    C-type lectin receptors (CLRs) represent a broad and diversified family of pattern recognition receptors (PRRs) that are mainly expressed on the...
    Kasturi Ganguly, Uday Kishore, Taruna Madan in Handbook of Cancer and Immunology
    Living reference work entry 2023
  16. PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade

    Blocking the inhibitory receptor PD-1 on antitumour T lymphocytes is the main rationale underlying the clinical successes of cancer immunotherapies...

    C. Donini, F. Galvagno, ... D. Sangiolo in British Journal of Cancer
    Article 20 July 2023
  17. Helicobacter pylori Virulence Factors, Pathogenicity, and Gastric Cancer

    Gastric cancer is a common cancer with a high incidence and mortality rate worldwide. Unfortunately, early-stage gastric cancer is asymptomatic....
    Alaa M. Elgohary, Nourhan M. Gomaa, ... Mustafa H. Frag in Gastrointestinal Cancers: An Interdisciplinary Approach
    Chapter 2023
  18. Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor

    Background

    RASopathies are genetic syndromes affecting development and having variable cancer predisposition. These disorders are clinically related...

    Giulia Fasano, Stefania Petrini, ... Antonella Lauri in Molecular Medicine
    Article Open access 09 April 2024
  19. [18F]FDG PET/CT Imaging in Cancer Treatment with Checkpoint Inhibitors

    In the last decade, the development of new therapeutic agents modulating the activity of the immune system and boosting its response against cancer...
    Barbara Catalfamo, Egesta Lopci in Handbook of Cancer and Immunology
    Living reference work entry 2023
Did you find what you were looking for? Share feedback.